Breaking News

Cangene Receives WinRho Approval

Portugal clears WinRho 1500 LQ

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Cangene Corp.‘s wholly owned subsidiary, Cangene Europe Limited, has received marketing authorization approval for WinRho 1500 LQ in Portugal from the National Authority of Medicines and Health Products, IP (INFARMED). The company has received a national license to market the product in Portugal for two indications: to prevent Rh0(D) immunization women that are in Rh0(D) negative, and to treat Rh0(D) negative patients after incompatible Rh0(D) positive blood transfusions or other products...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters